BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+4.42%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$1.14B
AUM Growth
+$1.14B
(+11%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
11.49%
Top 10 Holdings %
Top 10 Hldgs %
48.07%
Holding
60
New
9
Increased
13
Reduced
15
Closed
3
Top Buys
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$31.3M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$24.6M |
| 3 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$17.6M |
| 4 |
AC Immune
ACIU
|
$16.1M |
| 5 |
Replimune Group
REPL
|
$14.7M |
Top Sells
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$11.6M |
| 2 |
ARQL
Arqule Inc
ARQL
|
$9.17M |
| 3 |
AnaptysBio
ANAB
|
$8.48M |
| 4 |
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
|
$5.91M |
| 5 |
Forte Biosciences
FBRX
|
$4.4M |
Sector Composition
| 1 | Healthcare | 84.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
51
DELISTED
Regulus Therapeutics
RGLS
| $2.7M | 0.24% |
13,685,204
| – | – |
|
|
KDNY
52
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.12M | 0.19% |
287,776
-8,189
| -3% | -$60.2K |
|
|
FRTX
53
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $1.83M | 0.16% |
1,332,605
| – | – |
|
54
ESSA Pharma
EPIX
$11.3M
| $1.73M | 0.15% |
576,771
+23,980
| +4% | +$72K |
|
|
RLM
55
DELISTED
Realm Therapeutics plc American Depositary Shares
RLM
| $1.17M | 0.1% |
+360,866
| New | +$1.17M |
|
|
LOXO
56
DELISTED
Loxo Oncology, Inc
LOXO
| $699K | 0.06% |
4,089
| – | – |
|
57
Zymeworks
ZYME
$1.06B
| $311K | 0.03% |
19,804
| – | – |
|
|
58
Forte Biosciences
FBRX
$137M
| – | – |
-471,007
| Closed | -$4.4M |
|
|
59
Ironwood Pharmaceuticals
IRWD
$211M
| – | – |
-606,715
| Closed | -$11.6M |
|
|
ONCT
60
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| – | – |
-386,134
| Closed | -$5.91M |
|